Effect of lipid-lowering strategies on tubular cell biology.
nate, farnesyl-pyrophosphate (FPP,) and geranylgeranyl-HMG-CoA reductase inhibitors were shown to reduce pyrophosphate (GGPP), whereas cholesterol and other progressive glomerulosclerosis and tubulointerstitial fiproducts of the mevalonate pathway were inactive. Imbrosis in different models of renal injury. In Dahl saltmunoblot analysis showed that lovastatin decreased sensitive rats on a high-salt diet, 22 weeks treatment membrane-bound p21 ras and inhibited FCS-induced c-fos with lovastatin reduced serum cholesterol, albuminuria, and c-jun expression in rPTCs. Furthermore, gel shift blood pressure, and focal glomerulosclerosis, but did not assay demonstrated the functional impairment of AP-1 alter glomerular hemodynamics [16] . Similarly, in 5/6 DNA binding activity in nuclear extracts from lovastatinnephrectomized rats and in obese Zucker rats, HMGtreated cells. Much like the lovastatin effects on upCoA reductase inhibition lessened albuminuria and messtream components of p21 ras activated AP-1 pathway, the angial matrix expansion and cellularity [17, 18] . Unidecrease of AP-1 binding activity was totally prevented nephrectomized nephrotic rats treated for 60 days with by mevalonate. lovastatin had similar proteinuria but better inulin clear-
In vivo, tubular cell proliferation and c-fos protein ance and less pronounced glomerulosclerosis as comexpression were increased two weeks after nephrectomy, pared with placebo-treated rats [19] . Importantly, in the as measured by Western blot and immunohistochemical Han:SPRD rat model of hereditary polycystic kidney analysis of proliferative cell nuclear antigen staining (6.3 disease, lovastatin-treated heterozygous males had milder vs. 1.6 labeled cell per field, P Ͻ 0.02). Lovastatin admindisease with smaller cysts and lower plasma urea as comistration (4 mg/kg/d) reduced c-fos protein expression pared with untreated animals [20] .
and tubular cell proliferation (6.3 vs. 3.5 labeled cell per However, the precise mechanisms of these protective field, P Ͻ 0.02) two weeks after nephrectomy. effects remain unclear. In the rat remnant kidney model,
In summary, these results demonstrated that HMGthe protective effect of lovastatin on renal function two CoA reductase inhibitors were antiproliferative both in weeks after nephrectomy was associated with elective vitro and in vivo in epithelial tubule cells and that this vasoconstriction of glomerular efferent vessels and eneffect was exerted via inhibition of the p21 ras -activated hanced reactivity to acetylcholine of afferent glomerular and AP-1-dependent mitogenic cascade (Fig. 1A) . vessels [21] . Lovastatin reduced MCP-1 expression and macrophage infiltration in nephrotic rats [22] . In the anti-HMG-CoA reductase inhibitors induce apoptosis in Thy-1.1 rat model of glomerulonephritis, simvastatin proximal tubular cell suppressed mesangial cell proliferation and macrophage Twenty-four hour HMG-CoA reductase inhibitorinfiltration and reduced matrix expansion, although it did treated mouse proximal tubule cells (mPTCs) displayed not affect circulating lipids [23] . Clearly, a large amount typical features of apoptosis, as evidenced by nucleus of data has now established that HMG-CoA reductase cleavage after staining with Hoescht 33258, DNA ladder inhibitors could regulate cell functions in vitro and in pattern on gel electrophoresis, and DNA fragmentation vivo independently from a cholesterol-lowering effect.
as measured by the ratio of fragmented DNA over intact We evaluated the antiproliferative and apoptotic ef-DNA following [ 3 H]-thymidine labeling [25] . HFPA refects and the fibrinolytic activity of different HMG-CoA produced the apoptotic effect of lovastatin; conversely, reductase inhibitors in primary cultured proximal tubulovastatin-induced apoptosis was totally prevented by lar cells and in isolated proximal tubules.
GGPP but only partially by FPP. Actin filament disruption by cytochalasin D or C3 exo-HMG-CoA reductase inhibitors inhibit renal enzyme, a selective inhibitor of the geranylgeranylated cell growth activated Rho protein, induced apoptosis in mPTCs. Treatment of RPT cells during 48 hours with lovasSimilarly, lovastatin caused early actin filament network tatin, simvastatin, and compactin reduced fetal calf sedisruption, as evidenced by immunofluorescence study rum (FCS)-induced [ 3 H]-thymidine incorporation in a of rhodamine phalloidin staining. This effect was reconcentration-dependent manner, with IC 50 values in the versed by GGPP and preceded evidence of apoptosis. micromolar range [24] . Likewise, lovastatin blocked
Interleukin-1␤-converting enzyme inhibitor II, a proteBrdUrd incorporation, as assessed by immunocytochemase inhibitor, had no effect on the apoptosis induced by ical studies. The proliferative effect of EGF was similarly either cytochalasin D or lovastatin. abolished by lovastatin. Tyrosine kinase and mitogenThis suggested that in mPTCs, the inhibition of isoactivated protein kinase inhibitors, AP-1 antisense oligoprenoid production was instrumental in HMG-CoA renucleotides as well as the farnesyl-transferase inhibitor hydroxy-farnesyl-phosphonic acid (HFPA) decreased ductase inhibitor-induced apoptosis, and that inactiva- tion of Rho protein and disruption of actin filaments tPA and uPA and a decrease in PA inhibitor-1 (PAI-1) might play a role in the induction of apoptosis (Fig. 1B) .
activities. In vitro, supernatants, cytosols, and membranes of renal proximal tubular cells in primary culture HMG-CoA reductase inhibitors and the tubular had no detectable uPA activity, and lovastatin (0.1 to fibrinolytic system 10.0 m) induced an increase in tPA and a decrease in PAI-1 activities and antigens. Proximal tubules freshly isolated from rats treated for These effects were selectively prevented by mevalotwo days with lovastatin (4 mg/kg/day) showed increased nate and GGPP. Accordingly, HFPA did not reproduce tissue-type plasminogen activator (tPA) and urokinase the effect of lovastatin. C3 exoenzyme reproduced the (uPA) activities and antigens [26] . Incubation with lovaseffect of lovastatin on tPA and PAI-1 activity, and furtatin (5 m) of proximal tubules isolated from untreated rats induced a time-dependent (6 to 48 hr) increase in thermore, it blocked the preventive effect of GGPP. The
S-95
effect of lovastatin on actin stress fibers network was proliferative effect of lovastatin; on the other hand, disruption of actin filaments and inhibition of geranylgerasubsequently analyzed. The results of immunofluorescence studies demonstrated disruption of cellular actin nylation of Rho protein appear pivotal in the apoptotic and fibrinolytic activity of lovastatin. stress fibers in lovastatin-treated cells, which was reversed by GGPP and reproduced by the C3 exoenzyme. These results suggested that the cytoarchitecture of the ACKNOWLEDGMENTS cells regulated tPA and PAI-1 activities and that lovas- increased apoptosis, and enhanced fibrinolytic activity. 15 . Ghosh PM, Mott GE, Ghosh-Choudhury N, Radnik RA, Stapleton ML, Ghidoni JJ, Kreisberg JI: Lovastatin induces apoptoInhibition of the p21 ras /AP1 cascade is critical in the anti-
